Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Theodor Kudlich"'
Autor:
Alexander Weich, Dorothee Rogoll, Sophia Gawlas, Lars Mayer, Wolfgang Weich, Judit Pongracz, Theodor Kudlich, Alexander Meining, Michael Scheurlen
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 367 (2021)
Loss of Somatostatin Receptor 2 (SSTR2) expression and rising CXC Chemokine Receptor Type 4 (CXCR4) expression are associated with dedifferentiation in neuroendocrine tumors (NET). In NET, CXCR4 expression is associated with enhanced metastatic and i
Externí odkaz:
https://doaj.org/article/af20b1d9117c4910a653e3f629e61628
Autor:
Ralph Melcher, Waltraud Zopf, Elena Hartmann, Andreas Rosenwald, Holger Hoehn, Michael Schmid, Theodor Kudlich, Michael Scheurlen, Hardi Luehrs
Publikováno v:
Cellular Oncology, Vol 30, Iss 6, Pp 507-507 (2008)
Externí odkaz:
https://doaj.org/article/dde8f1f08aff40a5afba35fc3924fee4
Autor:
Alexander Hann, Sven Flemming, Stanislaus Reimer, Kaja Groneberg, Theodor Kudlich, Christoph-Thomas Germer, Alexander Meining
Publikováno v:
Gut. 71(11)
Autor:
Sebastian Maasberg, Ulrich-Frank Pape, Christian Fottner, Peter E. Goretzki, Martin Anlauf, Dieter Hörsch, Birgit Cremer, Dominik M. Schulte, Detlef Quietzsch, Frank Scheerer, Gabriele Pöpperl, Thorsten D. Poeppel, Nehara Begum, Christian Grohé, Anja Rinke, Ursula Plöckinger, Betram Wiedenmann, Rudolf Arnold, Peter Neuhaus, Wolfram H. Knapp, Hendrick Lehnert, Christoph Auernhammer, Marianne Pavel, Ludwig Fischer von Weikersthal, Bernd Schmidt, Harald H. Klein, Markus Essler, Jörg-Dietrich Neumann, Susanne Hamann, Frank Steffens, Frank Demtröder, Anke Kröcher, Flavius Zoicas, Harald Lahner, Frank Weber, Michael Geißler, Andreas Raffel, Markus Krausch, Patrick Zimmermann, Markus M. Lerch, Thomas Wirth, Matthias Lang, Samer Ezziddin, Frank Lammert, Marina Bischoff, Annelore Altendorf-Hofmann, Lothar Müller, Albrecht Hoffmeister, Silke Klose, Thomas J. Musholt, Stefan Post, Ralf Gertler, Hubert Scheuerlein, Tanja Bergmann, Guido Bisping, Andreas Knauerhase, Bernhard Rendenbach, Volker Groß, Michael Scheurlen, Heiner Mönig, Theodor Kudlich, Patricia Grabowski, Felix Watza, Klemens Scheidhauer, Elke Möbius
Publikováno v:
Onkologische Welt. 10:182-192
ZusammenfassungNeuroendokrine Neoplasien (NEN) umfassen eine seltene Tumorentität mit heterogener Biologie, Prognose und therapeutischen Optionen. In Zusammenhang mit der kürzlichen Publikation der ersten deutschen Leitlinie zur Diagnostik und Ther
Autor:
Alexander Weich, Wolfgang Weich, Michael Scheurlen, Alexander Meining, Dorothee Rogoll, Judit E. Pongracz, Lars Mayer, Theodor Kudlich, Sophia Gawlas
Publikováno v:
Diagnostics, Vol 11, Iss 367, p 367 (2021)
Diagnostics
Volume 11
Issue 2
Pages: 367
Diagnostics
Volume 11
Issue 2
Pages: 367
Loss of Somatostatin Receptor 2 (SSTR2) expression and rising CXC Chemokine Receptor Type 4 (CXCR4) expression are associated with dedifferentiation in neuroendocrine tumors (NET). In NET, CXCR4 expression is associated with enhanced metastatic and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb2e354597ea9075c7f32a6c9c62e81
https://doi.org/10.3390/diagnostics11020367
https://doi.org/10.3390/diagnostics11020367
Autor:
M Peschka, D Rogoll, Theodor Kudlich, L Mayer, A Weich, Rudolf A. Werner, A Meining, M Scheurlen
Publikováno v:
DGVS Digital: BEST OF DGVS.
Publikováno v:
Zeitschrift für Gastroenterologie. 55:e1-e27
Publikováno v:
Zeitschrift für Gastroenterologie. 55:e1-e27
Autor:
Theodor Kudlich, Ann-Kathrin Koschker, Monika Rau, Jan Meertens, Christian Jurowich, Ilona Hering, Andreas Geier, Lisa Reichert, Johannes Weiss
Publikováno v:
Scandinavian Journal of Gastroenterology. 51:1263-1268
Prevalence of non-alcoholic fatty liver disease is rising in the Western world and reaches up to 90% in patients undergoing bariatric surgery. Fibroscan(®) as a non-invasive tool for liver stiffness measurement (LSM) has several limitations in morbi
Autor:
Niklas Beyersdorf, Anne-Kristin Schilling, Monika Rau, Christian Jurowich, Ilona Hering, Theodor Kudlich, Johannes M. Weiss, Heike Bantel, Andreas Geier, Jan Meertens, Heike M. Hermanns
Publikováno v:
The Journal of Immunology. 196:97-105
Nonalcoholic fatty liver disease is increasing in prevalence. It can be subdivided into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Five to twenty percent of cases progress from NAFL to NASH. Increased hepatic Th17 cells